System, method and apparatus for electrosurgical instrument with movable suction sheath

Information

  • Patent Grant
  • 8317786
  • Patent Number
    8,317,786
  • Date Filed
    Friday, September 25, 2009
    15 years ago
  • Date Issued
    Tuesday, November 27, 2012
    12 years ago
Abstract
An electrosurgical instrument having active and return electrodes with a movable suction sheath for variable fluid and debris removal during surgical procedures is disclosed. The suction apparatus has an outer sheath that is external to a shaft to provide a lumen. The sheath assembly is axially movable relative to the fluid aspiration element between first and second positions for treating the target site and fluid and debris removal, respectively. The first position positions the distal end of the shaft axially distal to a leading edge of the sheath assembly. The second position positions the distal leading edge of the sheath assembly axially adjacent to the end of the shaft. The fluid aspiration element comprises an inner lumen extending through the shaft, and at least one port extending radially through the shaft. The port is in communication with the inner lumen. A vacuum provides suction through the port and inner lumen.
Description
TECHNICAL FIELD

The present invention relates in general to electrosurgical instruments and, in particular, to an electrosurgical instrument with a fluid aspiration device for controllably removing fluid from a treatment site. More particularly, the present invention relates to a system, method and apparatus for an electrosurgical instrument having active and return electrodes with a movable suction sheath for variable fluid and debris removal during surgical procedures.


DESCRIPTION OF THE RELATED ART

In some electrosurgical procedures an instrument (see, e.g., U.S. Pat. Nos. 5,683,366 and 6,235,020, which are incorporated herein by reference) has an active electrode and a return electrode that are used to treat body tissue. Treatment with this instrument may include, for example, coagulation, cutting, ablating, abrading or puncturing the tissue. In various designs, a current path is created between the active and return electrodes, thereby generating a limited plasma field between the electrodes and applying the plasma to the tissue, preferably without passing the current through the tissue. The current path may be created by providing an electrically conductive fluid at the target, or in some instances immersing the target site within electrically conductive fluid. It is preferred that the electrically conductive fluid has sufficient conductivity such that the fluid is ionized when subject to sufficient radio frequency (RF) electrical energy to thereby form the limited plasma. The conductive fluid path is an electrolyte, such as saline, lactated ringers solution, or conductive gels. One of the electrodes, referred to as the active electrode, is designed to generate a higher current density relative to other electrode, which is referred to as the return electrode. The source of the current is a high frequency voltage applied across the electrodes.


Conventional electrosurgical cutting or resecting devices tend to leave the operating field cluttered with tissue fragments that have been removed or resected from the target tissue. To maintain proper visualization of the surgical site, these fragments and ablative byproducts are periodically or continuously aspirated from the treatment site. Some electrosurgical instruments, such as U.S. Pat. No. 6,589,237, and U.S. Pat. App. Pub. 2006/0259025, which are incorporated herein by reference, employ a vacuum system having a suction inlet on a distal end portion to aspirate resected tissue fragments and ablation byproducts such as fluid and gas bubbles. The vacuum system is disposed at least partly within a lumen defined by an elongate member. Preferably, the instrument maintains a conductive fluid bridge and resultant plasma field between the electrodes during use regardless of the orientation of the electrodes relative to the target tissue and regardless of the operation of the vacuum aspiration element.


For some applications, electrosurgical instruments with these types of aspiration systems provide insufficient fluid and debris removal from the treatment site. Aspiration may be too slow because the aspiration rate is limited by the shaft size, or may be prone to clogging. Although separate or additional aspiration systems may be employed for such applications, they add significant cost and complication to such procedures, while requiring multiple suctions lines and crowding of the surgical area. Further, certain procedures may require aspiration of relatively large volumes of fluid from the target site, resulting in difficulties in generating and maintaining a plasma from the ionized electrically conductive fluid in the vicinity of the active electrode. Thus, an improved solution that overcomes the limitations of the prior art would be desirable.


BRIEF SUMMARY OF THE INVENTION

Embodiments of a system, method, and apparatus for an electrosurgical instrument having active and return electrodes with a movable suction sheath for variable fluid and debris removal during surgical procedures are disclosed. The electrosurgical suction apparatus has an outer sheath that is external to a shaft to provide an annular fluid and debris removal channel or lumen. The sheath assembly is axially slidable and movable relative to the fluid aspiration element between first and second positions for treating the target site and controllable fluid and debris removal, respectively. The first position comprises positioning the distal leading edge of the sheath assembly axially proximal to the distal end of the shaft. The second position may comprise positioning the distal leading edge of the sheath assembly axially adjacent to the distal end of the shaft, or axially distal to the distal end of the shaft.


The fluid aspiration element comprises an inner lumen extending through the shaft, and at least one port extending radially through the shaft. The at least one port is in fluid communication with the inner lumen. A vacuum source is connected to the inner lumen for providing suction through the port and inner lumen. In one embodiment, the sheath assembly comprises a tube that is slidably movable relative to and concentric with the shaft. The tube defines an annular space or outer lumen between the tube and the shaft and has a radial seal. The radial seal is disposed between an outer surface of the shaft and an inner surface of the tube and sealingly engages the shaft and the tube.


In another embodiment, the sheath assembly has a range of motion between the first and second positions that provides a variable level of fluid and debris removal. Preferably, the sheath assembly is movable to provide a minimal level of fluid and debris removal in the first position, to a maximum level of fluid and debris removal in the second position. The fluid aspiration element comprises an inner lumen extending through a portion of the shaft, and first and second plurality of ports extending radially through the shaft in fluid communication with the inner lumen. The first and second plurality of ports are preferably axially spaced apart. A vacuum source is connected to the inner lumen and to the outer lumen proximal to the radial seal. Aspiration is preferably provided only through an opening to the inner lumen at the distal end of the shaft when the sheath assembly is in the first position despite the outer lumen proximal the radial seals being under vacuum pressure, as the radial seal creates a bypass preventing aspiration through the outer lumen and first and second plurality of ports. When the sheath assembly is in an intermediate or second position, the vacuum source may provide a sequential suction path through the inner lumen as well as through the outer lumen that is distal to the radial seal, the first plurality of ports, and the second plurality of ports via the outer lumen proximal to the radial seal.


The invention may further comprise a method for treating tissue including the steps of positioning an active electrode adjacent to tissue; applying a first high frequency voltage between the active electrode and a return electrode; positioning a sheath assembly in a first position, the first position creating an aspiration region around the active electrode; aspirating fluid from the region adjacent to the active electrode; retracting the sheath assembly to a second position; advancing the active electrode into the tissue; applying a second high frequency voltage between the return electrode and a coagulation electrode; and returning the sheath assembly to the first position to aspirate fluid from a region axially spaced away from the active electrode.


The foregoing and other objects and advantages of the present invention will be apparent to those skilled in the art, in view of the following detailed description of the present invention, taken in conjunction with the appended claims and the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS

So that the manner in which the features and advantages of the present disclosure are attained and can be understood in more detail, a more particular description of the apparatus and methods briefly summarized above may be had by reference to the embodiments thereof that are illustrated in the appended drawings. However, the drawings illustrate only some embodiments of this disclosure and therefore are not to be considered limiting of its scope as the invention may admit to other equally effective embodiments.



FIG. 1 is a sectional side view of one embodiment of an electrosurgical instrument shown in a first position and is constructed in accordance with the invention;



FIG. 2 is a sectional side view of the electrosurgical instrument of FIG. 1, shown in a second position, and is constructed in accordance with the invention;



FIGS. 3-5 are sectional side views of another embodiment of an electrosurgical instrument shown in three different positions and is constructed in accordance with the invention;



FIGS. 6 and 7 are enlarged schematic sectional side views of the electrosurgical instrument of FIGS. 3-5 in operation and is constructed in accordance with the invention; and



FIG. 8 is a schematic diagram of one embodiment of a system for operating an electrosurgical instrument and is constructed in accordance with the invention.



FIG. 9 shows a method in accordance with at least some embodiments.





DETAILED DESCRIPTION

Before the present invention is described in detail, it is to be understood that this invention is not limited to particular variations set forth herein as various changes or modifications may be made to the invention described and equivalents may be substituted without departing from the spirit and scope of the invention. As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present invention. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process act(s) or step(s) to the objective(s), spirit or scope of the present invention. All such modifications are intended to be within the scope of the claims made herein.


Methods recited herein may be carried out in any order of the recited events which is logically possible, as well as the recited order of events. Furthermore, where a range of values is provided, it is understood that every intervening value, between the upper and lower limit of that range and any other stated or intervening value in that stated range is encompassed within the invention. Also, it is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein.


All existing subject matter mentioned herein (e.g., publications, patents, patent applications and hardware) is incorporated by reference herein in its entirety except insofar as the subject matter may conflict with that of the present invention (in which case what is present herein shall prevail). The referenced items are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present invention is not entitled to antedate such material by virtue of prior invention.


Reference to a singular item, includes the possibility that there are plural of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “an,” “said” and “the” include plural referents unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation. Last, it is to be appreciated that unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.


The treatment device of the present disclosure may have a variety of configurations as described above. However, one variation employs a treatment device using Coblation® technology.


As stated above, the assignee of the present disclosure developed Coblation® technology. Coblation® technology involves the application of a high frequency voltage difference between one or more active electrode(s) and one or more return electrode(s) to develop high electric field intensities in the vicinity of the target tissue. The high electric field intensities may be generated by applying a high frequency voltage that is sufficient to vaporize an electrically conductive fluid over at least a portion of the active electrode(s) in the region between the tip of the active electrode(s) and the target tissue. The electrically conductive fluid may be a liquid or gas, such as isotonic saline, blood, extracelluar or intracellular fluid, delivered to, or already present at, the target site, or a viscous fluid, such as a gel, applied to the target site.


When the conductive fluid is heated enough such that atoms vaporize off the surface faster than they recondense, a gas is formed. When the gas is sufficiently heated such that the atoms collide with each other causing a release of electrons in the process, an ionized gas or plasma is formed (the so-called “fourth state of matter”). Generally speaking, plasmas may be formed by heating a gas and ionizing the gas by driving an electric current through it, or by shining radio waves into the gas. These methods of plasma formation give energy to free electrons in the plasma directly, and then electron-atom collisions liberate more electrons, and the process cascades until the desired degree of ionization is achieved. A more complete description of plasma can be found in Plasma Physics, by R. J. Goldston and P. H. Rutherford of the Plasma Physics Laboratory of Princeton University (1995), the complete disclosure of which is incorporated herein by reference.


As the density of the plasma or vapor layer becomes sufficiently low (i.e., less than approximately 1020 atoms/cm3 for aqueous solutions), the electron mean free path increases to enable subsequently injected electrons to cause impact ionization within the vapor layer. Once the ionic particles in the plasma layer have sufficient energy, they accelerate towards the target tissue. Energy evolved by the energetic electrons (e.g., 3.5 eV to 5 eV) can subsequently bombard a molecule and break its bonds, dissociating a molecule into free radicals, which then combine into final gaseous or liquid species. Often, the electrons carry the electrical current or absorb the radio waves and, therefore, are hotter than the ions. Thus, the electrons, which are carried away from the tissue towards the return electrode, carry most of the plasma's heat with them, allowing the ions to break apart the tissue molecules in a substantially non-thermal manner.


By means of this molecular dissociation (rather than thermal evaporation or carbonization), the target tissue structure is volumetrically removed through molecular disintegration of larger organic molecules into smaller molecules and/or atoms, such as hydrogen, oxygen, oxides of carbon, hydrocarbons and nitrogen compounds. This molecular disintegration completely removes the tissue structure, as opposed to dehydrating the tissue material by the removal of liquid within the cells of the tissue and extracellular fluids, as is typically the case with electrosurgical desiccation and vaporization. A more detailed description of this phenomena can be found in commonly assigned U.S. Pat. No. 5,697,882 the complete disclosure of which is incorporated herein by reference.


In some applications of the Coblation® technology, high frequency (RF) electrical energy is applied in an electrically conducting media environment to shrink or remove (i.e., resect, cut, or ablate) a tissue structure and to seal transected vessels within the region of the target tissue. Coblation® technology is also useful for sealing larger arterial vessels, e.g., on the order of about 1 mm in diameter. In such applications, a high frequency power supply is provided having an ablation mode, wherein a first voltage is applied to an active electrode sufficient to effect molecular dissociation or disintegration of the tissue, and a coagulation mode, wherein a second, lower voltage is applied to an active electrode (either the same or a different electrode) sufficient to heat, shrink, and/or achieve hemostasis of severed vessels within the tissue.


The amount of energy produced by the Coblation® device may be varied by adjusting a variety of factors, such as: the number of active electrodes; electrode size and spacing; electrode surface area; asperities and sharp edges on the electrode surfaces; electrode materials; applied voltage and power; current limiting means, such as inductors; electrical conductivity of the fluid in contact with the electrodes; density of the fluid; and other factors. Accordingly, these factors can be manipulated to control the energy level of the excited electrons. Since different tissue structures have different molecular bonds, the Coblation® device may be configured to produce energy sufficient to break the molecular bonds of certain tissue but insufficient to break the molecular bonds of other tissue. For example, fatty tissue (e.g., adipose) has double bonds that require an energy level substantially higher than 4 eV to 5 eV (typically on the order of about 8 eV) to break. Accordingly, the Coblation® technology generally does not ablate or remove such fatty tissue; however, it may be used to effectively ablate cells to release the inner fat content in a liquid form. Of course, factors may be changed such that these double bonds can also be broken in a similar fashion as the single bonds (e.g., increasing voltage or changing the electrode configuration to increase the current density at the electrode tips). A more complete description of this phenomena can be found in commonly assigned U.S. Pat. Nos. 6,355,032, 6,149,120 and 6,296,136, the complete disclosures of which are incorporated herein by reference.


The active electrode(s) of a Coblation® device may be supported within or by an inorganic insulating support positioned near the distal end of the instrument shaft. The return electrode may be located on the instrument shaft, on another instrument or on the external surface of the patient (i.e., a dispersive pad). The proximal end of the instrument(s) will include the appropriate electrical connections for coupling the return electrode(s) and the active electrode(s) to a high frequency power supply, such as an electrosurgical generator.


In one example of a Coblation® device for use with the present disclosure, the return electrode of the device is typically spaced proximally from the active electrode(s) a suitable distance to avoid electrical shorting between the active and return electrodes in the presence of electrically conductive fluid. In many cases, the distal edge of the exposed surface of the return electrode is spaced about 0.5 mm to 25 mm from the proximal edge of the exposed surface of the active electrode(s), preferably about 1.0 mm to 5.0 mm. Of course, this distance may vary with different voltage ranges, conductive fluids, and depending on the proximity of tissue structures to active and return electrodes. The return electrode will typically have an exposed length in the range of about 1 mm to 20 mm.


A Coblation® treatment device for use according to the present disclosure may use a single active electrode or an array of active electrodes spaced around the distal surface of a catheter or probe. In the latter embodiment, the electrode array usually includes a plurality of independently current-limited and/or power-controlled active electrodes to apply electrical energy selectively to the target tissue while limiting the unwanted application of electrical energy to the surrounding tissue and environment resulting from power dissipation into surrounding electrically conductive fluids, such as blood, normal saline, and the like. The active electrodes may be independently current-limited by isolating the terminals from each other and connecting each terminal to a separate power source that is isolated from the other active electrodes. Alternatively, the active electrodes may be connected to each other at either the proximal or distal ends of the catheter to form a single wire that couples to a power source.


In one configuration, each individual active electrode in the electrode array is electrically insulated from all other active electrodes in the array within the instrument and is connected to a power source which is isolated from each of the other active electrodes in the array or to circuitry which limits or interrupts current flow to the active electrode when low resistivity material (e.g., blood, electrically conductive saline irrigant or electrically conductive gel) causes a lower impedance path between the return electrode and the individual active electrode. The isolated power sources for each individual active electrode may be separate power supply circuits having internal impedance characteristics which limit power to the associated active electrode when a low impedance return path is encountered. By way of example, the isolated power source may be a user selectable constant current source. In this embodiment, lower impedance paths will automatically result in lower resistive heating levels since the heating is proportional to the square of the operating current times the impedance. Alternatively, a single power source may be connected to each of the active electrodes through independently actuatable switches, or by independent current limiting elements, such as inductors, capacitors, resistors and/or combinations thereof. The current limiting elements may be provided in the instrument, connectors, cable, controller, or along the conductive path from the controller to the distal tip of the instrument. Alternatively, the resistance and/or capacitance may occur on the surface of the active electrode(s) due to oxide layers which form selected active electrodes (e.g., titanium or a resistive coating on the surface of metal, such as platinum).


The Coblation® device is not limited to electrically isolated active electrodes, or even to a plurality of active electrodes. For example, the array of active electrodes may be connected to a single lead that extends through the catheter shaft to a power source of high frequency current.


The voltage difference applied between the return electrode(s) and the active electrode(s) will be at high or radio frequency, typically between about 5 kHz and 20 MHz, usually being between about 30 kHz and 2.5 MHz, preferably being between about 50 kHz and 500 kHz, often less than 350 kHz, and often between about 100 kHz and 200 kHz. In some applications, applicant has found that a frequency of about 100 kHz is useful because the tissue impedance is much greater at this frequency. In other applications, such as procedures in or around the heart or head and neck, higher frequencies may be desirable (e.g., 400-600 kHz) to minimize low frequency current flow into the heart or the nerves of the head and neck.


The RMS (root mean square) voltage applied will usually be in the range from about 5 volts to 1000 volts, preferably being in the range from about 10 volts to 500 volts, often between about 150 volts to 400 volts depending on the active electrode size, the operating frequency and the operation mode of the particular procedure or desired effect on the tissue (i.e., contraction, coagulation, cutting or ablation.)


Typically, the peak-to-peak voltage for ablation or cutting with a square wave form will be in the range of 10 volts to 2000 volts and preferably in the range of 100 volts to 1800 volts and more preferably in the range of about 300 volts to 1500 volts, often in the range of about 300 volts to 800 volts peak to peak (again, depending on the electrode size, number of electrons, the operating frequency and the operation mode). Lower peak-to-peak voltages will be used for tissue coagulation, thermal heating of tissue, or collagen contraction and will typically be in the range from 50 to 1500, preferably 100 to 1000 and more preferably 120 to 400 volts peak-to-peak (again, these values are computed using a square wave form). Higher peak-to-peak voltages, e.g., greater than about 800 volts peak-to-peak, may be desirable for ablation of harder material, such as bone, depending on other factors, such as the electrode geometries and the composition of the conductive fluid.


As discussed above, the voltage is usually delivered in a series of voltage pulses or alternating current of time varying voltage amplitude with a sufficiently high frequency (e.g., on the order of 5 kHz to 20 MHz) such that the voltage is effectively applied continuously (as compared with, e.g., lasers claiming small depths of necrosis, which are generally pulsed about 10 Hz to 20 Hz). In addition, the duty cycle (i.e., cumulative time in any one second interval that energy is applied) is on the order of about 50% for the present disclosure, as compared with pulsed lasers which typically have a duty cycle of about 0.0001%.


The preferred power source of the present disclosure delivers a high frequency current selectable to generate average power levels ranging from several milliwatts to tens of watts per electrode, depending on the volume of target tissue being treated, and/or the maximum allowed temperature selected for the instrument tip. The power source allows the user to select the voltage level according to the specific requirements of a particular neurosurgery procedure, cardiac surgery, arthroscopic surgery, dermatological procedure, ophthalmic procedures, open surgery or other endoscopic surgery procedure. For cardiac procedures and potentially for neurosurgery, the power source may have an additional filter, for filtering leakage voltages at frequencies below 100 kHz, particularly voltages around 60 kHz. Alternatively, a power source having a higher operating frequency, e.g., 300 kHz to 600 kHz may be used in certain procedures in which stray low frequency currents may be problematic. A description of one suitable power source can be found in commonly assigned U.S. Pat. Nos. 6,142,992 and 6,235,020, the complete disclosure of both patents are incorporated herein by reference for all purposes.


The power source may be current limited or otherwise controlled so that undesired heating of the target tissue or surrounding (non-target) tissue does not occur. In a presently preferred embodiment of the present invention, current limiting inductors are placed in series with each independent active electrode, where the inductance of the inductor is in the range of 10 uH to 50,000 uH, depending on the electrical properties of the target tissue, the desired tissue heating rate and the operating frequency. Alternatively, capacitor-inductor (LC) circuit structures may be employed, as described previously in U.S. Pat. No. 5,697,909, the complete disclosure of which is incorporated herein by reference. Additionally, current-limiting resistors may be selected. Preferably, these resistors will have a large positive temperature coefficient of resistance so that, as the current level begins to rise for any individual active electrode in contact with a low resistance medium (e.g., saline irrigant or blood), the resistance of the current limiting resistor increases significantly, thereby minimizing the power delivery from said active electrode into the low resistance medium (e.g., saline irrigant or blood).


Referring now to FIGS. 1-8, embodiments of a system, method and apparatus for an electrosurgical instrument having active and return electrodes with a movable suction sheath for variable fluid and debris removal during surgical procedures are disclosed. FIGS. 1 and 2 illustrate one embodiment of an electrosurgical suction apparatus 21 having an outer sheath 23 and grip 24 that is external to a shaft 25 to provide an annular fluid delivery channel 27 or lumen. The distal terminus of outer sheath 23 defines an annular fluid ingress 29 at a location proximal to return electrode 31.


The direction of flow of fluid and debris during use of apparatus 21 is indicated by the arrows. Electrically conductive fluid provided at the distal end of apparatus 21 forms a current flow path between active electrodes 33 and return electrode 31, and can facilitate generation of a plasma in the vicinity of active electrodes 33, as described hereinabove. Provision of an extraneous electrically conductive fluid may be particularly valuable in a dry field situation (e.g., in situations where there is a paucity of native electrically conductive bodily fluids, such as blood, synovial fluid, etc.). In an alternative embodiment, an electrically conductive fluid, such as saline, may be delivered to the distal end of suction apparatus 21 by a separate device (not shown).


The suction apparatus 21, or fluid and debris aspiration element, aspirates fluid and debris from a target site. For example, during an electrosurgical ablative procedure, it may be desirable to remove electrically conductive fluid, bodily fluids, resected tissue fragments and ablation by-products such as air bubbles from the target site to improve visibility and control the rate of ablation. The outer sheath 23, or sheath assembly, is disposed adjacent to the fluid aspiration element. The sheath assembly 23 is axially movable relative to the fluid aspiration element 21 between a first position (FIG. 1) for treating the target site and a second position (FIG. 2) for fluid and debris removal. The first position may comprise positioning a distal leading edge 29 of the sheath assembly 23 axially proximal to the distal end 33 of the shaft 25. The second position may comprise positioning the distal leading edge 29 of the sheath assembly 23 axially adjacent to the distal end 33 of the shaft 25, or alternatively axially distal to the distal end 33 of the shaft 25.


The fluid aspiration element 21 may comprise an inner lumen 35 extending through the shaft 25, and at least one port 37 (e.g., three shown) extending radially through the shaft 25. The port(s) 37 are in fluid communication with the inner lumen 35 as well as outer lumen 27, thereby creating an aspiration chamber under vacuum in the annular space surrounding shaft 25 and defined by sheath assembly 23 and seals 41. A vacuum source 39 (shown schematically) is connected to the inner lumen 35 for providing suction from outer lumen 27 through the port(s) 37 and inner lumen 35. The port 37 may comprise a plurality of ports that are located adjacent the distal end of the shaft 25 and axially spaced from the electrode assembly 31, 33.


In one embodiment, the sheath assembly 23 comprises a tube that is slidably movable relative to and concentric with the shaft 25. Grip 24 may be disposed on sheath assembly 23 in certain embodiments to provide an ergonomic interface for the user (e.g., with the user's finger) in order to ease movement and sliding of sheath assembly 23. The tube 23 defines an annular space or outer lumen 27 between the tube 23 and the shaft 25 and has a radial seal 41. The radial seal 41 is disposed between an outer surface of the shaft 25 and an inner surface of the tube 23 and sealingly engages the shaft 25 and the tube 23. The radial seal 41 may comprise a plurality of o-rings that are seated in an axial series of radial grooves 43 formed in the inner surface of the tube 23, with the radial grooves 43 being axially spaced from each other. The system may further comprising at least one spacer 45 (FIG. 2) located between the outer surface of the shaft 25 and the inner surface of the tube 23 for supporting and stabilizing the tube relative to the shaft along with the radial seal 41.


In the first position illustrated in FIG. 1, sheath assembly 23 is positioned to create a relatively low rate of suction from the target site and the area in the vicinity of the electrode terminal. In this first position, incidental fluid and debris are aspirated from the target site and adjacent to the electrode terminal. Additionally, the relatively low suction rate in the vicinity of active electrode 33 allows for the formation of an effective vapor layer and more efficient plasma for tissue treatment and ablation. Alternatively, in the second position illustrated in FIG. 2, edge 29 of sheath assembly 23 is positioned adjacent to or distal to active electrode 33 to create a larger aspiration field and a relatively higher suction rate from the target site and in vicinity of active electrode 33. In this second position, sheath assembly 23 is deployed for a considerable rate of aspiration and to focus on the aspiration of fluid and debris from the target site and adjacent to active electrode 33. Further, sheath assembly 23 may be deployed in the second position illustrated in FIG. 2 if the user detects the ablative effect on the target tissue is too intense, as the increased aspiration may mitigate the efficacy of the vapor layer and plasma formed at active electrode 33.


Referring now to the embodiments of FIGS. 3-7, the sheath assembly 123 may be provided with a range of motion between the first and second positions that provides a variable level of fluid and debris removal. Sheath assembly 123 is preferably slidable between a first deployed position where a minimal level of fluid and debris removal occurs (FIGS. 3 and 6), to a second deployed position where a maximum level of fluid and debris removal occurs (FIGS. 5 and 7). An intermediate level of fluid and debris removal is depicted in FIG. 4.


In these embodiments, the fluid aspiration element 121 comprises an inner lumen 135 extending through a portion of the shaft 125 and having an opening 134 at the distal end of shaft 125, and first and second ports 137, 138 extending radially through the shaft 125 in fluid communication with the inner lumen 135. The first and second ports 137, 138 are located on or adjacent to opposite axial ends of the inner lumen 135. The sheath assembly 123 comprises a tube that is slidably movable relative to and concentric with the shaft 125. Grip 124 may be disposed on sheath assembly 123 in certain embodiments to provide an ergonomic interface for the user (e.g., with the user's finger) in order to ease movement and sliding of sheath assembly 123. The tube 123 defines an annular space or outer lumen 127 between the tube 123 and the shaft 125 and has a radial seal 141. The radial seal 141 is disposed in the outer lumen 127 between an outer surface of the shaft 125 and an inner surface of the tube 123 and sealingly engages the shaft 125 and the tube 123.


A vacuum source 139 (e.g., indicated schematically) is connected to the inner lumen 135 and to the outer lumen 127 proximal to the radial seal 141. Referring now to FIG. 3, sheath assembly 123 is deployed such that seals 141 are disposed proximally of both the first and second ports 137, 138. In this configuration, no aspiration chamber is formed in the annular space between sheath assembly 123 and shaft 125 and distal seals 141, such that aspiration is provided only through opening 134 and inner lumen 135. In this configuration, first and second ports 137, 138 are at the same pressure with no net fluid flow therebetween and thereby fluidly bypassed by way of seals 141 isolating the first and second ports 137, 138 from the aspiration chamber and the portion of outer lumen 127 connected to vacuum source 139. When the sheath assembly 123 is in the intermediate position (FIG. 4) or in the second position (FIGS. 5 and 7), the vacuum source 139 provides a sequential suction path through inner lumen 135 via opening 134 as well as the outer lumen 127a that is distal to the radial seal 141, the first port 137, the inner lumen 135, the second port 138 and the outer lumen 127b proximal to the radial seal 141. Specifically, when sheath assembly 123 is disposed in the second position as depicted by FIG. 5, first port 137 and second port 137 are at different pressures creating an aspiration chamber under vacuum distal of seals 141 and allowing for net fluid flow between first port 137 and second port 138. As such, in this embodiment suction is available through both opening 134 and inner lumen 135 as well as through sheath assembly 123 and outer lumen 127. Further, the suction may be switched between inner lumen 135 via opening 134 or in combination with sheath assembly 123 and outer lumen 127. The first and second ports 137, 138 each may comprise a plurality of ports, with the first ports 137 being located adjacent the distal end of the shaft 125 and axially spaced from the electrode assembly 131, 133, and the second ports 138 being located proximal to the first ports 137.


In the first position illustrated in FIGS. 3 and 6, sheath assembly 123 is positioned to create a relatively low rate of suction through inner lumen 135 via opening 134 from the target site and the area in the vicinity of the electrode terminal. In this first position, incidental fluid and debris are aspirated from the target site and adjacent to the electrode terminal. Additionally, the relatively low suction rate in the vicinity of active electrode 133 allows for the formation of an effective vapor layer and more efficient plasma for tissue treatment and ablation. Alternatively, in the second position illustrated in FIGS. 5 and 7, a distal edge of sheath assembly 123 is positioned adjacent to or distal to active electrode 133 and in proximity to the target site to create a more aggressive aspiration field and a relatively higher suction rate from the target site and in vicinity of active electrode 133. In this second position, aspiration is available through both inner lumen 135 via opening 134 as well as outer lumen 127 via first and second ports 137, 138. As such, sheath assembly 123 is deployed for a considerable rate of aspiration and to focus on the aspiration of fluid and debris from the target site and adjacent to active electrode 133. Further, sheath assembly 123 may be deployed in the second position illustrated in FIGS. 5 and 7 if the user detects the ablative effect on the target tissue is too intense, as the increased aspiration may mitigate the efficacy of the vapor layer and plasma formed at active electrode 133.


Referring now to FIG. 8, an exemplary electrosurgical system 801 for treatment of tissue in “dry fields” is shown. System 801 also may be used in a “wet field,” i.e., the target site is immersed in electrically conductive fluid. However, this system is particularly useful in dry fields where the fluid is preferably delivered through an electrosurgical probe to the target site. As shown, electrosurgical system 801 generally comprises an electrosurgical hand piece or probe 21 connected to a power supply 803 for providing high frequency voltage to a target site and a fluid source 805 for supplying electrically conductive fluid 807 to probe 21. In addition, electrosurgical system 801 may include an endoscope (not shown) with a fiber optic head light for viewing the surgical site, particularly in sinus procedures or procedures in the ear or the back of the mouth. The endoscope may be integral with probe 21, or it may be part of a separate instrument.


As shown, probe 21 generally includes a proximal handle 811 and an elongate shaft 25 having an array 813 of active electrodes 33 at its distal end. A connecting cable 815 has a connector 816 for electrically coupling the active electrodes 33 to power supply 803. The active electrodes 33 are electrically isolated from each other and each of the terminals is connected to an active or passive control network within power supply 803 by means of a plurality of individually insulated conductors (not shown). A fluid supply tube 817 is connected to a fluid tube 818 of probe 21 for supplying electrically conductive fluid 807 to the target site.


The system 801 also includes a vacuum source as described herein that is coupled to a suction lumen or tube in the probe 21 for aspirating the target site. Suction tube 845 is fluidly coupled with inner lumen 35 of probe 21 and in communication with suction pump 840 to thereby provide vacuum source 39 previously referenced herein. Suction pump 840 may encompass any suitable fluid transport apparatus. Suction pump 840 may comprise a positive displacement pump such as, for example, a peristaltic pump. In some embodiments the suction pump 840 may comprise a vacuum pump and canister assembly such as may be provided via a wall outlet in a surgical suite.


Power supply 803 may comprise an operator controllable voltage level adjustment 819 to change the applied voltage level, which is observable at a voltage level display 821. Power supply 803 also includes first, second and third foot pedals 823, 825, 827 and a cable 829 that is removably coupled to power supply 803. The foot pedals 823, 825, 827 allow the surgeon to remotely adjust the energy level applied to active electrodes 33. In an exemplary embodiment, first foot pedal 823 is used to place the power supply into the ablation mode and second foot pedal 825 places power supply 803 into the “coagulation” mode. The third foot pedal 827 allows the user to adjust the voltage level within the “ablation” mode.


In the ablation mode, a sufficient voltage is applied to the active electrodes to establish the requisite conditions for molecular dissociation of the tissue (i.e., vaporizing a portion of the electrically conductive fluid, ionizing charged particles within the vapor layer, and accelerating these charged particles against the tissue). As discussed above, the requisite voltage level for ablation will vary depending on the number, size, shape and spacing of the electrodes, the distance to which the electrodes extend from the support member, etc. Once the surgeon places the power supply in the ablation mode, voltage level adjustment 819 or third foot pedal 827 may be used to adjust the voltage level to adjust the degree or aggressiveness of the ablation.


Of course, it will be recognized that the voltage and modality of the power supply may be controlled by other input devices. However, applicant has found that foot pedals are convenient methods of controlling the power supply while manipulating the probe during a surgical procedure.


In the coagulation mode, the power supply 803 applies a low enough voltage to the active electrodes (or the coagulation electrode) to avoid vaporization of the electrically conductive fluid and subsequent molecular dissociation of the tissue. The surgeon may automatically toggle the power supply between the ablation and coagulation modes by alternately stepping on foot pedals 823, 825, respectively. This allows the surgeon to quickly move between coagulation and ablation in situ, without having to remove his/her concentration from the surgical field or without having to request an assistant to switch the power supply.


By way of example, as the surgeon is sculpting soft tissue in the ablation mode, the probe typically will simultaneously seal and/or coagulate small severed vessels within the tissue. However, larger vessels, or vessels with high fluid pressures (e.g., arterial vessels) may not be sealed in the ablation mode. Accordingly, the surgeon can simply actuate foot pedal 825, automatically lowering the voltage level below the threshold level for ablation, and apply sufficient pressure onto the severed vessel for a sufficient period of time to seal and/or coagulate the vessel. After this is completed, the surgeon may quickly move back into the ablation mode by actuating foot pedal 823.


Referring now to FIG. 9, a method (900) for treating tissue in accordance with at least some of the embodiments described herein is illustrated, including the steps of: positioning an active electrode adjacent to tissue (910); applying a first high frequency voltage between the active electrode and a return electrode (920); positioning a sheath assembly in a first position, the first position creating an aspiration region proximal from the active electrode (930); aspirating fluid from the region proximal from the active electrode (940); deploying the sheath assembly to a second position, the first position creating an aspiration region adjacent to the active electrode (950); aspirating fluid from the region adjacent to the active (960).


While the invention has been shown or described in only some of its forms, it should be apparent to those skilled in the art that it is not so limited, but is susceptible to various changes without departing from the scope of the invention.

Claims
  • 1. A system for treating tissue, comprising: an electrosurgical instrument having a shaft with a proximal end and a distal end;an electrode assembly comprising at least one active electrode positioned on the distal end of the shaft and a return electrode positioned on the shaft and axially spaced from the at least one active electrode;an aspiration element for aspirating fluid and debris from a target site, the aspiration element comprising an inner lumen extending through a portion of the shaft, first and second ports extending radially through the shaft in fluid communication with the inner lumen, wherein the first and second ports are axially spaced apart; anda sheath assembly disposed adjacent to the aspiration element, the sheath assembly defining an annular space around the shaft and being axially movable relative to the aspiration element between a first position and a second position, wherein at least one radial seal is disposed within the annular space;wherein the sheath assembly in the second position disposes the radial seal adjacent the second port and the sheath assembly in the first position spaces the radial seal proximally from the second port.
  • 2. A system according to claim 1, wherein a distal leading edge of the sheath assembly is disposed axially proximal to the distal end of the shaft in the first position, and the distal leading edge of the sheath assembly is disposed substantially axially adjacent to the distal end of the shaft in the second position.
  • 3. A system according to claim 1, further comprising a vacuum source connected to the inner lumen for providing suction through the first and second ports and inner lumen.
  • 4. A system according to claim 1, wherein the first and second ports each comprise a plurality of ports that are located adjacent the distal end of the shaft and axially spaced from the electrode assembly.
  • 5. A system according to claim 1 wherein the sheath assembly comprises an elongate tube that is slidably movable relative to and concentric with the shaft, the tube having a distal terminus moveable so as to be disposed adjacent the electrosurgical instrument distal end and wherein the tube defines an outer lumen for annular fluid flow between the elongate tube and the shaft, the radial seal being disposed between an outer surface of the shaft and an inner surface of the tube and sealingly engaging the shaft and the tube.
  • 6. A system according to claim 5, wherein the radial seal comprises a plurality of o-rings that are seated in an axial series of radial grooves formed in the inner surface of the tube, the radial grooves being axially spaced from each other.
  • 7. A system according to claim 1, wherein the first position is operable to aspirate at a distance spaced away from the active electrode and the second position is operable to aspirate adjacent to the active electrode.
  • 8. A system according to claim 1, wherein the sheath assembly has a range of motion between the first and second positions that provides a variable level of fluid and debris removal, from a minimal level of fluid and debris removal in the first position, to a maximum level of fluid and debris removal in the second position.
  • 9. A system for treating tissue, comprising: an electrosurgical instrument having a shaft with a proximal end and a distal end;an electrode assembly comprising at least one active electrode positioned on the distal end of the shaft and a return electrode positioned on the shaft and axially spaced from the at least one active electrode;an aspiration element for aspirating fluid and debris from a target site comprising an inner lumen extending through a portion of the shaft, and first and second ports extending radially through the shaft in fluid communication with the inner lumen, the first and second ports axially spaced apart;a sheath assembly disposed adjacent to the aspiration element, the sheath assembly defining an annular space around the shaft and being axially movable relative to the aspiration element between a first position and a second position;wherein the sheath assembly comprises a tube that is slidably movable relative to and concentric with the shaft, the tube defining an outer lumen between the tube and the shaft and having at least one radial seal, the at least one radial seal being disposed in the outer lumen between an outer surface of the shaft and an inner surface of the tube and sealingly engaging the shaft and the tube;
  • 10. A system according to claim 9, wherein the first and second ports each comprise a plurality of ports, with the first ports being located adjacent the distal end of the shaft and axially spaced from the electrode assembly, and the second ports being located proximal to the first ports.
  • 11. An electrosurgical instrument for removing tissue from a target site within or on a patient's body comprising: a shaft having proximal and distal end portions;an electrode assembly comprising at least one active electrode positioned on the distal end portion of the shaft and a return electrode positioned on the shaft and axially spaced from the at least one active electrode;an aspiration element for aspirating fluid and debris from the target site, the aspiration element coupled to a vacuum system, wherein the aspiration element comprises an inner lumen disposed in the shaft and a plurality of ports extending radially through the shaft and axially spaced from one another, the plurality of ports in fluid communication with the inner lumen; anda movable sheath assembly disposed adjacent to the shaft and defining an annular space around the shaft, the sheath assembly comprising an elongate tube with a distal end portion movable from a first position wherein the distal end portion is retracted proximally from the electrode assembly to a second position wherein the distal end portion is adjacent to the electrode assembly;wherein the elongate tube defines an outer lumen between the elongate tube and the shaft and wherein at least one radial seal is disposed between an outer surface of the shaft and an inner surface of the elongate tube to sealingly engage the shaft and the elongate tube.
  • 12. The electrosurgical instrument of claim 11, the inner lumen having a distal opening.
  • 13. An electrosurgical instrument for removing tissue from a target site within or on a patient's body comprising: a shaft having proximal and distal end portions;an electrode assembly comprising at least one active electrode positioned on the distal end port of the shaft and a return electrode positioned on the shaft and axially spaced from the at least one active electrode;an aspiration element for aspirating fluid and debris from the target site, the aspiration element coupled to a vacuum system;a movable sheath assembly disposed adjacent to the shaft and defining an annular space around the shaft, the sheath assembly having a distal end portion and being movable from a first position wherein the distal end portion is retracted proximally from the electrode assembly to a second position wherein the distal end portion is adjacent to the electrode assembly; and wherein the sheath assembly comprises a tube that is slidably movable relative to and concentric with the shaft, the tube defining an outer lumen between the tube and the shaft and having at least one radial seal, the at least one radial seal being disposed between an outer surface of the shaft and an inner surface of the tube and sealingly engaging the shaft and the tube;wherein the aspiration element comprises an inner lumen disposed in the shaft and a first and second plurality of ports extending radially through the shaft and axially spaced away from each other, the plurality of ports in fluid communication with the inner lumen and the annular space; andwherein the first and second plurality of ports are fluidly bypassed in the first position, and wherein the first and second plurality of ports are fluidly connected to the outer lumen proximal the at least one radial seal in the second position.
US Referenced Citations (545)
Number Name Date Kind
2050904 Trice Aug 1936 A
2056377 Wappler Oct 1939 A
2275167 Bierman Mar 1942 A
3633425 Sanford Jan 1972 A
3699967 Anderson Oct 1972 A
3812858 Oringer May 1974 A
3815604 O'Malley et al. Jun 1974 A
3828780 Morrison, Jr. Aug 1974 A
3901242 Storz Aug 1975 A
3920021 Hiltebrandt Nov 1975 A
3939839 Curtiss Feb 1976 A
3945375 Banko Mar 1976 A
3970088 Morrison Jul 1976 A
4033351 Hetzel Jul 1977 A
4040426 Morrison, Jr. Aug 1977 A
4043342 Morrison, Jr. Aug 1977 A
4074718 Morrison, Jr. Feb 1978 A
4092986 Schneiderman Jun 1978 A
4116198 Roos Sep 1978 A
4181131 Ogiu Jan 1980 A
4184492 Meinke et al. Jan 1980 A
4202337 Hren et al. May 1980 A
4203444 Bonnell et al. May 1980 A
4228800 Degler, Jr. et al. Oct 1980 A
4232676 Herczog Nov 1980 A
4240441 Khalil Dec 1980 A
4248231 Herczog et al. Feb 1981 A
4269174 Adair May 1981 A
4326529 Doss et al. Apr 1982 A
4381007 Doss Apr 1983 A
4411266 Cosman Oct 1983 A
4429694 McGreevy Feb 1984 A
4474179 Koch Oct 1984 A
4476862 Pao Oct 1984 A
4483338 Bloom et al. Nov 1984 A
4532924 Auth et al. Aug 1985 A
4548207 Reimels Oct 1985 A
4567890 Ohta et al. Feb 1986 A
4582057 Auth et al. Apr 1986 A
4590934 Malis et al. May 1986 A
4593691 Lindstrom et al. Jun 1986 A
4641649 Walinsky Feb 1987 A
4658817 Hardy Apr 1987 A
4660571 Hess et al. Apr 1987 A
4674499 Pao Jun 1987 A
4682596 Bales et al. Jul 1987 A
4706667 Roos Nov 1987 A
4709698 Johnston et al. Dec 1987 A
4719914 Johnson Jan 1988 A
4727874 Bowers et al. Mar 1988 A
4736743 Daikuzono Apr 1988 A
4737678 Hasegawa Apr 1988 A
4762128 Rosenbluth Aug 1988 A
4765331 Petruzzi et al. Aug 1988 A
4785806 Deckelbaum Nov 1988 A
4785823 Eggers et al. Nov 1988 A
4805616 Pao Feb 1989 A
4813429 Eshel et al. Mar 1989 A
4823791 D'Amelio et al. Apr 1989 A
4827911 Broadwin et al. May 1989 A
4832048 Cohen May 1989 A
4860752 Turner et al. Aug 1989 A
4903696 Stasz et al. Feb 1990 A
4907589 Cosman Mar 1990 A
4920978 Colvin May 1990 A
4931047 Broadwin et al. Jun 1990 A
4936281 Stasz Jun 1990 A
4936301 Rexroth et al. Jun 1990 A
4940064 Desai Jul 1990 A
4943290 Rexroth et al. Jul 1990 A
4955377 Lennox et al. Sep 1990 A
4966597 Cosman Oct 1990 A
4967765 Turner et al. Nov 1990 A
4968314 Michaels Nov 1990 A
4976709 Sand Dec 1990 A
4976711 Parins et al. Dec 1990 A
4979948 Geddes et al. Dec 1990 A
4998933 Eggers et al. Mar 1991 A
5007437 Sterzer Apr 1991 A
5007908 Rydell Apr 1991 A
5009656 Reimels Apr 1991 A
5035696 Rydell Jul 1991 A
5037421 Boutacoff et al. Aug 1991 A
5047026 Rydell Sep 1991 A
5047027 Rydell Sep 1991 A
5057105 Malone et al. Oct 1991 A
5057106 Kasevich et al. Oct 1991 A
5061266 Hakky Oct 1991 A
5078717 Parins et al. Jan 1992 A
5080660 Buelna Jan 1992 A
5083565 Parins Jan 1992 A
5084044 Quint Jan 1992 A
5084045 Helenowski Jan 1992 A
5085659 Rydell Feb 1992 A
5088997 Delahuerga et al. Feb 1992 A
5092339 Geddes et al. Mar 1992 A
5093877 Aita et al. Mar 1992 A
5098431 Rydell Mar 1992 A
5099840 Goble et al. Mar 1992 A
5102410 Dressel Apr 1992 A
5103804 Abele et al. Apr 1992 A
5108391 Flachenecker et al. Apr 1992 A
RE33925 Bales et al. May 1992 E
5112330 Nishigaki et al. May 1992 A
5122138 Manwaring Jun 1992 A
5125928 Parins et al. Jun 1992 A
5137530 Sand Aug 1992 A
5147354 Boutacoff et al. Sep 1992 A
5151098 Loertscher Sep 1992 A
5156151 Imran Oct 1992 A
5167659 Ohtomo et al. Dec 1992 A
5171311 Rydell et al. Dec 1992 A
5176528 Fry et al. Jan 1993 A
5178620 Eggers et al. Jan 1993 A
5190517 Zieve et al. Mar 1993 A
5191883 Lennox et al. Mar 1993 A
5192280 Parins Mar 1993 A
5195959 Smith Mar 1993 A
5197466 Marchosky et al. Mar 1993 A
5197963 Parins Mar 1993 A
5207675 Canady May 1993 A
5217455 Tan Jun 1993 A
5217457 Delahuerga et al. Jun 1993 A
5217459 Kamerling Jun 1993 A
5230334 Klopotek Jul 1993 A
5234428 Kaufman Aug 1993 A
5246438 Langberg Sep 1993 A
5249585 Turner et al. Oct 1993 A
5261410 Alfano et al. Nov 1993 A
5267994 Gentelia et al. Dec 1993 A
5267997 Farin et al. Dec 1993 A
5269794 Rexroth Dec 1993 A
5273524 Fox et al. Dec 1993 A
5277201 Stern Jan 1994 A
5277696 Hagen Jan 1994 A
5279299 Imran Jan 1994 A
5281216 Klicek Jan 1994 A
5281218 Imran Jan 1994 A
5282797 Chess Feb 1994 A
5282799 Rydell Feb 1994 A
5290273 Tan Mar 1994 A
5290282 Casscells Mar 1994 A
5293868 Nardella Mar 1994 A
5295956 Bales et al. Mar 1994 A
5300069 Hunsberger et al. Apr 1994 A
5300099 Rudie Apr 1994 A
5301687 Wong et al. Apr 1994 A
5304169 Sand Apr 1994 A
5304170 Green Apr 1994 A
5306238 Fleenor Apr 1994 A
5312395 Tan et al. May 1994 A
5312400 Bales et al. May 1994 A
5314406 Arias et al. May 1994 A
5318563 Malis et al. Jun 1994 A
5322507 Costello et al. Jun 1994 A
5324254 Phillips Jun 1994 A
5330470 Hagen Jul 1994 A
5330518 Neilson et al. Jul 1994 A
5334140 Phillips Aug 1994 A
5334183 Wuchinich Aug 1994 A
5334193 Nardella Aug 1994 A
5335668 Nardella Aug 1994 A
5336217 Buys et al. Aug 1994 A
5336220 Ryan et al. Aug 1994 A
5336443 Eggers Aug 1994 A
5342357 Nardella Aug 1994 A
5348554 Imran et al. Sep 1994 A
5366443 Eggers et al. Nov 1994 A
5370642 Keller Dec 1994 A
5370644 Langberg Dec 1994 A
5370675 Edwards et al. Dec 1994 A
5374261 Yoon Dec 1994 A
5374265 Sand Dec 1994 A
5375588 Yoon Dec 1994 A
5380277 Phillips Jan 1995 A
5380316 Aita et al. Jan 1995 A
5383876 Nardella Jan 1995 A
5383917 Desai et al. Jan 1995 A
5389096 Aita et al. Feb 1995 A
5395312 Desai Mar 1995 A
5395363 Billings et al. Mar 1995 A
5400267 Denen et al. Mar 1995 A
5401272 Perkins Mar 1995 A
5403311 Abele et al. Apr 1995 A
5405376 Mulier et al. Apr 1995 A
5417687 Nardella et al. May 1995 A
5419767 Eggers et al. May 1995 A
5445634 Keller May 1995 A
5423803 Tankovich Jun 1995 A
5423810 Goble et al. Jun 1995 A
5423844 Miller Jun 1995 A
5423882 Jackman et al. Jun 1995 A
5431649 Mulier et al. Jul 1995 A
5432882 Jackman et al. Jul 1995 A
5433708 Nichols et al. Jul 1995 A
5436566 Thompson et al. Jul 1995 A
5437662 Nardella Aug 1995 A
5437664 Cohen et al. Aug 1995 A
5438302 Goble Aug 1995 A
5441499 Fritzsch Aug 1995 A
5451224 Goble et al. Sep 1995 A
5454809 Janssen Oct 1995 A
5458596 Lax et al. Oct 1995 A
5462545 Wang et al. Oct 1995 A
5484435 Fleenor et al. Jan 1996 A
5487385 Avitall Jan 1996 A
5490850 Ellman et al. Feb 1996 A
5496312 Klicek Mar 1996 A
5496314 Eggers Mar 1996 A
5496317 Goble et al. Mar 1996 A
5505710 Dorsey, III Apr 1996 A
5514130 Baker May 1996 A
5520685 Wojciechowicz May 1996 A
5536267 Edwards et al. Jul 1996 A
5542928 Evans et al. Aug 1996 A
5545161 Imran Aug 1996 A
5554152 Aita Sep 1996 A
5556397 Long et al. Sep 1996 A
5562703 Desai Oct 1996 A
5569242 Lax et al. Oct 1996 A
5571100 Goble et al. Nov 1996 A
5579764 Goldreyer Dec 1996 A
5584872 LaFontaine et al. Dec 1996 A
5607391 Klinger et al. Mar 1997 A
5607421 Jeevanandam et al. Mar 1997 A
5609151 Mulier et al. Mar 1997 A
5626576 Janssen May 1997 A
5633578 Eggers et al. May 1997 A
5643255 Organ Jul 1997 A
5647869 Goble et al. Jul 1997 A
5653692 Masterson et al. Aug 1997 A
5660836 Knowlton Aug 1997 A
5662680 Desai Sep 1997 A
5676693 LaFontaine Oct 1997 A
5681282 Eggers et al. Oct 1997 A
5681308 Edwards et al. Oct 1997 A
5683366 Eggers et al. Nov 1997 A
5688267 Panescu et al. Nov 1997 A
5697281 Eggers et al. Dec 1997 A
5697536 Eggers et al. Dec 1997 A
5697882 Eggers et al. Dec 1997 A
5697909 Eggers et al. Dec 1997 A
5700262 Acosta et al. Dec 1997 A
5713896 Nardella Feb 1998 A
5725524 Mulier et al. Mar 1998 A
5743870 Edwards Apr 1998 A
5743903 Stern et al. Apr 1998 A
5746746 Garito et al. May 1998 A
5749869 Lindenmeier et al. May 1998 A
5755753 Knowlton May 1998 A
5766153 Eggers et al. Jun 1998 A
5769843 Abela et al. Jun 1998 A
5769847 Panescu et al. Jun 1998 A
5782795 Bays Jul 1998 A
5785705 Baker Jul 1998 A
5800429 Edwards Sep 1998 A
5800431 Brown Sep 1998 A
5807384 Mueller Sep 1998 A
5807395 Mulier et al. Sep 1998 A
5810764 Eggers et al. Sep 1998 A
5810802 Panescu et al. Sep 1998 A
5810809 Rydell Sep 1998 A
5836875 Webster, Jr. Nov 1998 A
5843019 Eggers et al. Dec 1998 A
5843078 Sharkey Dec 1998 A
5855277 Apps et al. Jan 1999 A
5860951 Eggers Jan 1999 A
5860974 Abele Jan 1999 A
5860975 Goble et al. Jan 1999 A
5871469 Eggers et al. Feb 1999 A
5871524 Knowlton Feb 1999 A
5873855 Eggers et al. Feb 1999 A
5876398 Mulier et al. Mar 1999 A
5885277 Korth Mar 1999 A
5888198 Eggers et al. Mar 1999 A
5891095 Eggers et al. Apr 1999 A
5891134 Goble et al. Apr 1999 A
5893848 Negus et al. Apr 1999 A
5895386 Odell et al. Apr 1999 A
5897553 Mulier Apr 1999 A
5902272 Eggers et al. May 1999 A
5904681 West, Jr. May 1999 A
5906613 Mulier et al. May 1999 A
5919219 Knowlton Jul 1999 A
5944715 Goble et al. Aug 1999 A
5954716 Sharkey et al. Sep 1999 A
5964754 Osypka Oct 1999 A
5976127 Lax Nov 1999 A
5980516 Mulier et al. Nov 1999 A
5980545 Pacala et al. Nov 1999 A
5984919 Hilal et al. Nov 1999 A
6004319 Goble et al. Dec 1999 A
6007533 Casscells et al. Dec 1999 A
6007570 Sharkey et al. Dec 1999 A
6013076 Goble et al. Jan 2000 A
6015406 Goble et al. Jan 2000 A
6016809 Mulier et al. Jan 2000 A
6024733 Eggers et al. Feb 2000 A
6027501 Goble et al. Feb 2000 A
6030383 Benderev Feb 2000 A
6032673 Savage et al. Mar 2000 A
6032674 Eggers et al. Mar 2000 A
6039734 Goble et al. Mar 2000 A
6042580 Simpson Mar 2000 A
6045532 Eggers et al. Apr 2000 A
6047700 Eggers et al. Apr 2000 A
6053172 Hovda et al. Apr 2000 A
6056746 Goble et al. May 2000 A
6063079 Hovda et al. May 2000 A
6063081 Mulier et al. May 2000 A
6066134 Eggers et al. May 2000 A
6068628 Fanton et al. May 2000 A
6074386 Goble et al. Jun 2000 A
6090106 Goble et al. Jul 2000 A
6091995 Ingle et al. Jul 2000 A
6093186 Goble et al. Jul 2000 A
6096037 Mulier et al. Aug 2000 A
6102046 Weinstein et al. Aug 2000 A
6105581 Eggers et al. Aug 2000 A
6109268 Thapliyal et al. Aug 2000 A
6110169 Mueller et al. Aug 2000 A
6117109 Eggers et al. Sep 2000 A
6126682 Sharkey et al. Oct 2000 A
6142992 Cheng et al. Nov 2000 A
6149620 Baker et al. Nov 2000 A
6152923 Ryan Nov 2000 A
6156031 Aita et al. Dec 2000 A
6159194 Eggers et al. Dec 2000 A
6159208 Hovda et al. Dec 2000 A
6168593 Sharkey et al. Jan 2001 B1
6174309 Wrublewski et al. Jan 2001 B1
6179824 Eggers et al. Jan 2001 B1
6179836 Eggers et al. Jan 2001 B1
6183469 Thapliyal et al. Feb 2001 B1
6190381 Olsen et al. Feb 2001 B1
6203542 Ellsberry et al. Mar 2001 B1
6210402 Olsen et al. Apr 2001 B1
6210405 Goble et al. Apr 2001 B1
6214001 Casscells et al. Apr 2001 B1
6217575 DeVore et al. Apr 2001 B1
6224592 Eggers et al. May 2001 B1
6228078 Eggers May 2001 B1
6228081 Goble May 2001 B1
6234178 Goble et al. May 2001 B1
6235020 Cheng et al. May 2001 B1
6235023 Lee et al. May 2001 B1
6237604 Burnside et al. May 2001 B1
6238391 Olsen et al. May 2001 B1
6238393 Mulier et al. May 2001 B1
6254600 Willink et al. Jul 2001 B1
6261286 Goble et al. Jul 2001 B1
6261311 Sharkey et al. Jul 2001 B1
6264650 Hovda Jul 2001 B1
6264652 Eggers et al. Jul 2001 B1
6267757 Aita et al. Jul 2001 B1
6270460 McCartan et al. Aug 2001 B1
6277112 Underwood et al. Aug 2001 B1
6280441 Ryan Aug 2001 B1
6283961 Underwood et al. Sep 2001 B1
6293942 Goble et al. Sep 2001 B1
6296636 Cheng et al. Oct 2001 B1
6296638 Davison et al. Oct 2001 B1
6302903 Mulier et al. Oct 2001 B1
6306134 Goble et al. Oct 2001 B1
6308089 von der Ruhr et al. Oct 2001 B1
6309387 Eggers et al. Oct 2001 B1
6312408 Eggers et al. Nov 2001 B1
6312429 Butbank et al. Nov 2001 B1
6315774 Daniel et al. Nov 2001 B1
6322494 Bullivant et al. Nov 2001 B1
6322549 Eggers et al. Nov 2001 B1
6325799 Goble Dec 2001 B1
6327505 Medhkour et al. Dec 2001 B1
6328736 Mulier et al. Dec 2001 B1
6336926 Goble Jan 2002 B1
6346107 Cucin Feb 2002 B1
6355006 Ryaby et al. Mar 2002 B1
6355032 Hovda et al. Mar 2002 B1
6358248 Mulier et al. Mar 2002 B1
6363937 Hovda et al. Apr 2002 B1
6364877 Goble et al. Apr 2002 B1
6379350 Sharkley et al. Apr 2002 B1
6379351 Thapliyal et al. Apr 2002 B1
6391025 Weinstein et al. May 2002 B1
6391028 Fanton et al. May 2002 B1
6398781 Goble et al. Jun 2002 B1
6409724 Penny et al. Jun 2002 B1
6416507 Eggers et al. Jul 2002 B1
6416508 Eggers et al. Jul 2002 B1
6416509 Goble et al. Jul 2002 B1
6432103 Ellsberry et al. Aug 2002 B1
6432105 Ellman et al. Aug 2002 B1
6468274 Alleyne et al. Oct 2002 B1
6468275 Wampler et al. Oct 2002 B1
6482201 Olsen et al. Nov 2002 B1
6482202 Goble et al. Nov 2002 B1
6491690 Goble et al. Dec 2002 B1
6497705 Comben Dec 2002 B2
6497706 Burbank et al. Dec 2002 B1
6510854 Goble Jan 2003 B2
6514250 Jahns et al. Feb 2003 B1
6517498 Burbank et al. Feb 2003 B1
6517535 Edwards Feb 2003 B2
6530922 Cosman Mar 2003 B2
6540741 Underwood et al. Apr 2003 B1
6557559 Eggers et al. May 2003 B1
6575968 Eggers et al. Jun 2003 B1
6575969 Rittman, III et al. Jun 2003 B1
6578579 Burnside Jun 2003 B2
6582423 Thapliyal et al. Jun 2003 B1
6589237 Woloszko et al. Jul 2003 B2
6595990 Weinstein et al. Jul 2003 B1
6597950 Linder et al. Jul 2003 B2
6602248 Sharps et al. Aug 2003 B1
6605085 Edwards Aug 2003 B1
6610059 West, Jr. Aug 2003 B1
6620156 Garito et al. Sep 2003 B1
6632193 Davison et al. Oct 2003 B1
6632220 Eggers et al. Oct 2003 B1
6632230 Barry Oct 2003 B2
6645203 Sharkey et al. Nov 2003 B2
6663628 Peters Dec 2003 B2
6695839 Sharkey et al. Feb 2004 B2
6699206 Burbank et al. Mar 2004 B2
6699244 Carranza et al. Mar 2004 B2
6702810 McClurken et al. Mar 2004 B2
6746447 Davison et al. Jun 2004 B2
6749604 Eggers et al. Jun 2004 B1
6749608 Garito et al. Jun 2004 B2
6763836 Tasto et al. Jul 2004 B2
6770071 Woloszko et al. Aug 2004 B2
6780178 Palanker et al. Aug 2004 B2
6780180 Goble et al. Aug 2004 B1
6796982 Carmel et al. Sep 2004 B2
6802842 Ellman et al. Oct 2004 B2
6805130 Tasto et al. Oct 2004 B2
6827725 Batchelor et al. Dec 2004 B2
6832996 Woloszko et al. Dec 2004 B2
6837887 Woloszko et al. Jan 2005 B2
6837888 Ciarrocca et al. Jan 2005 B2
6855143 Davison et al. Feb 2005 B2
6896674 Woloszko et al. May 2005 B1
6904303 Phan et al. Jun 2005 B2
6920883 Bessette et al. Jul 2005 B2
6929640 Underwood et al. Aug 2005 B1
6949096 Davison et al. Sep 2005 B2
6960204 Eggers et al. Nov 2005 B2
6974453 Woloszko et al. Dec 2005 B2
6979332 Adams Dec 2005 B2
6984231 Goble et al. Jan 2006 B2
6991631 Woloszko et al. Jan 2006 B2
7004941 Tvinnereim et al. Feb 2006 B2
7041102 Truckai et al. May 2006 B2
7070596 Woloszko et al. Jul 2006 B1
7090672 Underwood et al. Aug 2006 B2
7094215 Davison et al. Aug 2006 B2
7104986 Hovda et al. Sep 2006 B2
7131969 Hovda et al. Nov 2006 B1
7150747 McDonald et al. Dec 2006 B1
7169143 Eggers et al. Jan 2007 B2
7179255 Lettice et al. Feb 2007 B2
7184811 Phan et al. Feb 2007 B2
7186234 Dahla et al. Mar 2007 B2
7192428 Eggers et al. Mar 2007 B2
7201750 Eggers et al. Apr 2007 B1
7217268 Eggers et al. May 2007 B2
7241293 Davison Jul 2007 B2
7258690 Sutton et al. Aug 2007 B2
7261712 Burbank et al. Aug 2007 B2
7270658 Woloszko et al. Sep 2007 B2
7270659 Hovda et al. Sep 2007 B2
7270661 Dahla et al. Sep 2007 B2
7276063 Davison et al. Oct 2007 B2
7297143 Woloszko et al. Nov 2007 B2
7297145 Ormbsy et al. Nov 2007 B2
7318823 Sharps et al. Jan 2008 B2
7331956 Hovda et al. Feb 2008 B2
RE40156 Sharps et al. Mar 2008 E
7357798 Sharps et al. Apr 2008 B2
7387625 Hovda et al. Jun 2008 B2
7419488 Ciarrocca et al. Sep 2008 B2
7429260 Underwood et al. Sep 2008 B2
7429262 Woloszko et al. Sep 2008 B2
7435247 Woloszko et al. Oct 2008 B2
7442191 Hovda et al. Oct 2008 B2
7445618 Eggers et al. Nov 2008 B2
7449021 Underwood et al. Nov 2008 B2
7462178 Woloszko et al. Dec 2008 B2
7468059 Eggers et al. Dec 2008 B2
7488295 Burbank et al. Feb 2009 B2
7491200 Underwood et al. Feb 2009 B2
7507236 Eggers et al. Mar 2009 B2
7572251 Davison et al. Aug 2009 B1
7776034 Kampa Aug 2010 B2
7819863 Eggers et al. Oct 2010 B2
8038670 McClurken Oct 2011 B2
20020029036 Goble et al. Mar 2002 A1
20020049438 Sharkey et al. Apr 2002 A1
20020072739 Lee et al. Jun 2002 A1
20030013986 Saadat Jan 2003 A1
20030088245 Woloszko et al. May 2003 A1
20030130655 Woloszko et al. Jul 2003 A1
20030130711 Pearson et al. Jul 2003 A1
20030158545 Hovda et al. Aug 2003 A1
20030171743 Tasto et al. Sep 2003 A1
20030208196 Stone Nov 2003 A1
20030212396 Eggers et al. Nov 2003 A1
20040116922 Hovda et al. Jun 2004 A1
20040127893 Hovda Jul 2004 A1
20040230190 Dahla et al. Nov 2004 A1
20050004634 Hovda et al. Jan 2005 A1
20050119650 Sanders et al. Jun 2005 A1
20050251134 Woloszko et al. Nov 2005 A1
20050261754 Woloszko et al. Nov 2005 A1
20050288665 Woloszko et al. Dec 2005 A1
20060036237 Davison et al. Feb 2006 A1
20060095031 Ormsby May 2006 A1
20060106379 O'Brien et al. May 2006 A1
20060178670 Woloszko et al. Aug 2006 A1
20060189971 Eggers et al. Aug 2006 A1
20060253117 Hovda et al. Nov 2006 A1
20060259025 Dahla Nov 2006 A1
20070005051 Kampa Jan 2007 A1
20070010808 Dahla Jan 2007 A1
20070106288 Woloszko et al. May 2007 A1
20070149966 Dahla et al. Jun 2007 A1
20070161981 Sanders et al. Jul 2007 A1
20070208334 Woloszko et al. Sep 2007 A1
20070208335 Woloszko et al. Sep 2007 A1
20070213700 Davison et al. Sep 2007 A1
20070282323 Woloszko et al. Dec 2007 A1
20080021447 Davison et al. Jan 2008 A1
20080167645 Woloszko Jul 2008 A1
20080167646 Godara et al. Jul 2008 A1
20080234673 Marion et al. Sep 2008 A1
20080300590 Horne et al. Dec 2008 A1
20090069807 Eggers et al. Mar 2009 A1
20090138011 Epstein May 2009 A1
20090209958 Davison et al. Aug 2009 A1
20100042095 Bigley et al. Feb 2010 A1
20100152724 Marion et al. Jun 2010 A1
20100204690 Bigley et al. Aug 2010 A1
20110077646 Dahla et al. Mar 2011 A1
20110270242 Marion Nov 2011 A1
20120179157 Frazier et al. Jul 2012 A1
Foreign Referenced Citations (113)
Number Date Country
2521719 Nov 1976 DE
3930451 Mar 1991 DE
4425015 Jan 1996 DE
296 09 350 Aug 1996 DE
195 37 084 Apr 1997 DE
296 19 029 Apr 1997 DE
19850671 May 1999 DE
10254668 Jun 2004 DE
69822877 Jan 2005 DE
202008000276 Jun 2008 DE
102009057921 Jun 2010 DE
0 502 268 Sep 1992 EP
0 515 867 Dec 1992 EP
543123 May 1993 EP
0 597 463 May 1994 EP
774926 Mar 1995 EP
0 650 701 May 1995 EP
0703461 Mar 1996 EP
0740926 Nov 1996 EP
0 754 437 Jan 1997 EP
923907 Jun 1999 EP
0 694 290 Nov 2000 EP
1149564 Oct 2001 EP
1041933 Mar 2004 EP
2313949 Jan 1977 FR
2037167 Jul 1980 GB
2 308 979 Jul 1997 GB
2 308 980 Jul 1997 GB
2 308 981 Jul 1997 GB
2 327 350 Jan 1999 GB
2 327 351 Jan 1999 GB
2 327 352 Jan 1999 GB
2331247 May 1999 GB
2379878 Mar 2003 GB
2408936 Jun 2005 GB
57-57802 Apr 1982 JP
57-117843 Jul 1982 JP
57-183850 Nov 1982 JP
63-40099 Aug 1988 JP
9-501328 Feb 1997 JP
9003152 Apr 1990 WO
9007303 Jul 1990 WO
9113650 Sep 1991 WO
9221278 Dec 1992 WO
9313816 Jul 1993 WO
9320747 Oct 1993 WO
9403134 Feb 1994 WO
9404220 Mar 1994 WO
9408654 Apr 1994 WO
9410924 May 1994 WO
9414383 Jul 1994 WO
9426228 Nov 1994 WO
9505780 Mar 1995 WO
9505781 Mar 1995 WO
9505867 Mar 1995 WO
9510326 Apr 1995 WO
9530373 Nov 1995 WO
9534259 Dec 1995 WO
9600042 Jan 1996 WO
9607360 Mar 1996 WO
9634568 Nov 1996 WO
9635469 Nov 1996 WO
9639914 Dec 1996 WO
9639962 Dec 1996 WO
9639964 Dec 1996 WO
9639965 Dec 1996 WO
9639967 Dec 1996 WO
9700646 Jan 1997 WO
9700647 Jan 1997 WO
9715238 May 1997 WO
9718765 May 1997 WO
9724073 Jul 1997 WO
9724074 Jul 1997 WO
9724992 Jul 1997 WO
9724993 Jul 1997 WO
9724994 Jul 1997 WO
9725101 Jul 1997 WO
9732551 Sep 1997 WO
9733523 Sep 1997 WO
9734540 Sep 1997 WO
9741786 Nov 1997 WO
9744071 Nov 1997 WO
9748345 Dec 1997 WO
9748346 Dec 1997 WO
9807468 Feb 1998 WO
9814131 Apr 1998 WO
9817185 Apr 1998 WO
9817186 Apr 1998 WO
9827877 Jul 1998 WO
9827879 Jul 1998 WO
9827880 Jul 1998 WO
9830144 Jul 1998 WO
9834550 Aug 1998 WO
9834558 Aug 1998 WO
9838925 Sep 1998 WO
9839038 Sep 1998 WO
9900060 Jan 1999 WO
9920185 Apr 1999 WO
9942037 Aug 1999 WO
9944506 Sep 1999 WO
9951155 Oct 1999 WO
9951158 Oct 1999 WO
0009053 Feb 2000 WO
0126570 Apr 2001 WO
0187154 May 2001 WO
0195819 Dec 2001 WO
0236028 May 2002 WO
0278557 Oct 2002 WO
03024339 Mar 2003 WO
2005125287 Dec 2005 WO
2008073727 Jun 2008 WO
2009094392 Jul 2009 WO
2011071482 Jun 2011 WO
Related Publications (1)
Number Date Country
20110077643 A1 Mar 2011 US